Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiaqi Chai
Institutions:
China Aerospace Science and Industry Corporation (China),
Jiangsu Province Hospital,
Nanjing Medical University
Observed institutions:
China Aerospace Science and Industry Corporation (China),
Jiangsu Province Hospital,
Nanjing Medical University
ORCID:
0009-0007-9885-7561
Observed ORCID:
0009-0007-9885-7561
OpenAlex ID:
A5111268889
The use of peripheral CD3+γδ+Vδ2+ T lymphocyte cells in combination with the ALBI score to predict immunotherapy response in patients with advanced hepatocellular carcinoma: a retrospective study
2024
·
Shuhan Zhang
, Luyang Li
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
4
CD96: immunoregulation and its role and prospect in immunotherapy of primary hepatocellular carcinoma
2025
·
Jiaqi Chai
, Luyang Li
, et al.
·
European Journal of Gastroenterology & Hepatology
·
3
Angiography‐Based Index of Microcirculatory Resistance in Assessing the MVO and Infarct Size in STEMI Patients
2026
·
Tian Wu
, Xiaojiao Zhang
, et al.
·
Clinical Cardiology
·
1
PDF
Using higher cut-off values to diagnose acute myocardial infarction in patients with elevated hs-cTnT
2025
·
Tian Wu
, Jiaqi Chai
, et al.
·
Journal of Biomedical Research
·
1
PDF
Optimal radial artery diameter for predicting radial artery occlusion after transradial coronary catheterization
2026
·
Inam Ullah
, Tong Wang
, et al.
·
Clinical Research in Cardiology
CEP55 Drives Pancreatic Cancer Progression by Suppressing Ferroptosis
2026
·
Shuhan Zhang
, Jiaqi Chai
, et al.
·
BioFactors
Show more works
View as search
Works count:
6
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type